Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
32.88
Oct 22 • 3:59 PM ET Dollar change+0.11 Percentage change(0.34%)
Aftermarket Close
32.88
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
302.10M
Enterprise Value
335.20M
Income
-32.01M
Sales
109.81M
Book/sh
0.86
Cash/sh
1.68
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
108
IPO
Apr 07, 1994
P/E
-
Forward P/E
56.21
PEG
-
P/S
2.75
P/B
38.05
P/C
19.59
P/FCF
67.13
EV/EBITDA
24.15
EV/Sales
3.05
Quick Ratio
2.30
Current Ratio
2.58
Debt/Eq
6.11
LT Debt/Eq
6.06
Option/Short
No / Yes
EPS (ttm)
-3.71
EPS next Y
0.58
EPS next Q
0.06
EPS this Y
480.00%
EPS next Y
207.89%
EPS next 5Y
-
EPS past 3/5Y
-63.11% -41.80%
Sales past 3/5Y
31.03% 45.92%
EPS Y/Y TTM
-219.19%
Sales Y/Y TTM
12.93%
EPS Q/Q
77.64%
Sales Q/Q
8.93%
Insider Own
46.90%
Insider Trans
0.00%
Inst Own
18.25%
Inst Trans
-9.15%
ROA
-0.34%
ROE
-1.31%
ROIC
-57.08%
Gross Margin
90.77%
Oper. Margin
10.38%
Profit Margin
-29.15%
SMA20
-4.82%
SMA50
-5.14%
SMA200
30.37%
Trades
Shs Outstand
9.19M
Shs Float
4.88M
52W High
35.52 -7.43%
52W Low
16.05 104.90%
Volatility
4.45% 1.46%
ATR (14)
0.57
RSI (14)
21.97
Beta
1.22
Rel Volume
0.21
Avg Volume
293.90K
Volume
62,358
Perf Week
-6.30%
Perf Month
-6.46%
Perf Quarter
28.64%
Perf Half Y
71.88%
Perf YTD
40.81%
Perf Year
5.45%
Perf 3Y
17.51%
Perf 5Y
0.52%
Perf 10Y
558.92%
Prev Close
32.77
Price
32.88
Change %
0.34%
Date Action Analyst Rating Change Price Target Change
Jul-30-26Downgrade H.C. Wainwright Buy → Neutral $35
Apr-15-26Initiated Lake Street Buy $32
Mar-26-25Reiterated H.C. Wainwright Buy $50 → $51
Dec-23-24Initiated H.C. Wainwright Buy $50
May-20-22Resumed Cantor Fitzgerald Overweight $45 → $40
Jun-30-21Initiated Cantor Fitzgerald Overweight $45
Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Executive ChairmanMr. Ronald T. Nixon
PresidentMr. Seth D. Yon
Chief Financial OfficerMs. Elizabeth B. Taylor
Chief Operating OfficerMr. Jacob A. Waldrop
Principal Accounting OfficerMs. Ashley M. Mackey